High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Published Online: 2020-05-?
Journal: Nature MedicineLoading...
Authors: AnnChristine Thastrom•Congfen Li•Darren Tayama•David F. McDermott•Deepali Rishipathak•Edward E. Kadel•Hartmut Koeppen•Jane L. Grogan•Jonathan E. Rosenberg•Kenji Hashimoto•Kobe C. Yuen•Li-Fen Liu•Mahrukh A. Huseni•Michiel S. van der Heijden•Ning Leng•Patrick Williams•Priti S. Hegde•Romain Banchereau•Sanjeev Mariathasan•Shilpa Keerthivasan•Shravan Madireddi•Thomas Powles•Vinita Gupta•Xiadong Shen•Ying-Jiun Chen•Zora Modrusan
